Literature DB >> 8669836

Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study.

S Shintani1, T Funayama, Y Yoshihama, R E Alcalde, K Ootsuki, N Terakado, T Matsumura.   

Abstract

The tyrosine kinase receptor family, including the epidermal growth factor receptor (EGF-R), c-erbB2 and, more recently, the c-erbB3, has been recognized as being of particular importance in many human malignancies. This study was undertaken to define the role of c-erb B2 and c-erbB3 in adenoid cystic carcinomas (A.C.C.) of the salivary glands. Sixteen cases of A.C.C. were studied immunohistochemically, using antibodies against each erbB gene family product. EGF-R was not detected in any of these samples but c-erbB2 and c-erbB3 gene products (ERBB2and ERBB3) were demonstrated in all A.C.C. sections with some degree of straining. Tubular and cribriform patterns overexpressed particularly large amounts of ERBB2 and ERBB3. Strong staining was mainly demonstrated in tumor cells of the invasive area. These results suggested that overexpression of ERBB2 and ERBB3 is related to tumor differentiation and invasion in adenoid cystic carcinomas.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8669836

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

Review 1.  Molecular biology of adenoid cystic carcinoma.

Authors:  Jia Liu; Chunbo Shao; Marietta L Tan; David Mu; Robert L Ferris; Patrick K Ha
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

Review 2.  Human Epidermal Growth Factor Receptor 2 (HER2/neu) in Salivary Gland Carcinomas: A Review of Literature.

Authors:  Abdullah Mislat Alotaibi; Mohammed Ali Alqarni; Abdelrahman Alnobi; Bassel Tarakji
Journal:  J Clin Diagn Res       Date:  2015-02-01

3.  Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.

Authors:  Saori Matsubayashi; Toshio Yoshihara
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-20       Impact factor: 2.503

Review 4.  Evaluation of HER2/neu expression in different types of salivary gland tumors: a systematic review and meta-analysis.

Authors:  Aylar Javaheripour; Maedeh Vakili Saatloo; Nafiseh Vahed; Leili Faraji Gavgani; Maryam Kouhsoltani
Journal:  J Med Life       Date:  2022-05

5.  A study of HER-2/neu expression and silver binding nucleolar organizer regions (Ag NORs) in perilesional normal salivary gland tissue.

Authors:  Essam Taher M A Gaballah
Journal:  Saudi Dent J       Date:  2010-02-10

Review 6.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

7.  Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.

Authors:  Laura Vidal; Ming S Tsao; Gregory R Pond; Ezra E W Cohen; Roger B Cohen; Eric X Chen; Mark Agulnik; Sebastien Hotte; Eric Winquist; Scott Laurie; D Neil Hayes; James Ho; Janet Dancey; Lillian L Siu
Journal:  Head Neck       Date:  2009-08       Impact factor: 3.147

Review 8.  Systemic therapy in the management of metastatic or advanced salivary gland cancers.

Authors:  Aymen Lagha; Nesrine Chraiet; Mouna Ayadi; Sarra Krimi; Bassem Allani; Hela Rifi; Henda Raies; Amel Mezlini
Journal:  Head Neck Oncol       Date:  2012-05-04

9.  Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.

Authors:  Y Ito; T Takeda; M Sakon; M Tsujimoto; S Higashiyama; K Noda; E Miyoshi; M Monden; N Matsuura
Journal:  Br J Cancer       Date:  2001-05-18       Impact factor: 7.640

10.  Immunohistochemical Assessment of HER3 Expression in Odontogenic Cysts.

Authors:  Marieh Honarmand; Shirin Saravani; Nazanin Kamyab; Mehdi Jahantigh; Molouk Torabi Parizi
Journal:  Iran Red Crescent Med J       Date:  2015-11-06       Impact factor: 0.611

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.